News for 'Biocon Chairperson Kiran Mazumdar-Shaw'

We'll tap regional partners: Kiran Mazumdar-Shaw

We'll tap regional partners: Kiran Mazumdar-Shaw

Rediff.com14 Mar 2012

Biocon chairperson and managing director Kiran Mazumdar-Shaw is in a firefighting mode, as the company she founded was forced to call off a blockbuster deal with global pharmaceutical major Pfizer.

Biocon chief Kiran Mazumdar-Shaw tests Covid positive

Biocon chief Kiran Mazumdar-Shaw tests Covid positive

Rediff.com18 Aug 2020

'I have added to the covid count by testing positive. Mild symptoms and I hope it stays that way,' the 67-year-old biotechnology industry veteran said in a tweet.

Anil Ambani, Vinod Adani, Sachin Tendulkar, Kiran Mazumdar-Shaw named in Pandora Papers

Anil Ambani, Vinod Adani, Sachin Tendulkar, Kiran Mazumdar-Shaw named in Pandora Papers

Rediff.com4 Oct 2021

"Tendulkar's attorney said the cricket player's investment is legitimate and has been declared to tax authorities. Shakira's attorney said the singer declared her companies, which the attorney said do not provide tax advantages. Schiffer's representatives said the supermodel correctly pays her taxes in the UK, where she lives," it notes.

'Some are doing too much': Shivakumar on Bengaluru infra criticism

'Some are doing too much': Shivakumar on Bengaluru infra criticism

Rediff.com19 Oct 2025

Karnataka Deputy Chief Minister D K Shivakumar responds to criticism regarding Bengaluru's infrastructure, while industry leaders and opposition members voice their concerns.

Kiran Mazumdar's tweet praising Rohan Murty kicks up dust

Kiran Mazumdar's tweet praising Rohan Murty kicks up dust

Rediff.com23 Apr 2014

Proxy advisory firms say the praise on Twitter was uncalled for.

Biocon launches human insulin

Biocon launches human insulin

Rediff.com10 Nov 2004

India's largest biotech firm Biocon on Wednesday launched its "recombinant human insulin (r-DNA), Insugen

Biocon among most reputed biotech employers globally: Survey

Biocon among most reputed biotech employers globally: Survey

Rediff.com3 Nov 2015

Biocon Ltd on Tuesday said it has earned the distinction of being the only Asian biopharma company to feature among the top biotechnology employers in the world as ranked by Science magazine.

Potholes are everywhere, outside PM's house too: Shivakumar

Potholes are everywhere, outside PM's house too: Shivakumar

Rediff.com23 Sep 2025

'I want to tell big IT companies and others that such things (pothole issue) are everywhere, we are doing our job. It is there across the country, but we have a duty, we will do it'

Biocon CEO to replace Mukesh as IIM-B board chief

Biocon CEO to replace Mukesh as IIM-B board chief

Rediff.com19 Feb 2014

At the meeting of the Board of Governors of IIM Bengaluru held on February 11, the chairperson, Mukesh D Ambani, expressed his decision to step down, IIM-B said.

Biocon 03-04 net zooms 219%

Biocon 03-04 net zooms 219%

Rediff.com14 May 2004

Biotech firm Biocon India on Friday reported net profits of Rs 138.63 crore (Rs 1.39 billion) for the year 2003-04, a growth of 219 per cent over Rs 43.51 crore (Rs 435.1 million) recorded for the previous fiscal.

Karnataka Felicitates President Murmu

Karnataka Felicitates President Murmu

Rediff.com28 Sep 2022

On her first visit to any state in the Indian Union after being sworn in as President of the Republic, Rashtrapati Droupadi Murmu was felicitated in Bengaluru by some of that city's luminaries.

Don't give in to Mamata, India Inc urges govt

Don't give in to Mamata, India Inc urges govt

Rediff.com19 Sep 2012

Industry leaders have urged the government to carry forward the reforms process.

Biocon plans to invest Rs 500 crore

Biocon plans to invest Rs 500 crore

Rediff.com3 Sep 2003

Biotechnology major Biocon India Ltd plans to invest over Rs 500 crore on its expansion plans over the next two years.

Priyank Kharge's close aide among 6 booked for plot to kill BJP MLA

Priyank Kharge's close aide among 6 booked for plot to kill BJP MLA

Rediff.com29 Dec 2024

A case has been registered against Raju Kapanur, a close aide of Karnataka Minister Priyank Kharge, and five others in connection with a conspiracy to kill BJP MLA Basavaraj Mattimadu and other leaders. The case was registered based on a suicide note by a civil contractor, Sachin Panchal, who accused Kapanur and his aides of making death threats. The BJP has demanded that the case be handed over to the CBI, while Priyank Kharge has denied the allegations and accused the BJP of politicising Sachin's death.

Only four women among India's 100 richest

Only four women among India's 100 richest

Rediff.com26 Sep 2014

The four women have a collective wealth of $11.3 billion and account for a little more than three per cent of the total net worth of all on the coveted list whose collective wealth amount to $346 billion.

Biocon chief: Sebi's insider trading laws need an overhaul

Biocon chief: Sebi's insider trading laws need an overhaul

Rediff.com26 Jul 2021

When Biocon chairperson Kiran Majumdar-Shaw - well known for raising issues ranging from lack of civic services in Bengaluru to climate change - decided to take on the Indian stock market regulator, the Securities and Exchange Board of India (Sebi), she forced the Indian corporate world and legal community to take notice. In an interview to Business Standard, Majumdar-Shaw called a Sebi order to impose a fine on insider trading charges against a Biocon employee and an external consultant an "Agatha Christie" fiction, which destroyed the reputation of "innocent people". "The order is pure harassment and has caused huge reputational damage to us and goes against the principles of good governance promised by this government," Mazumdar-Shaw said. "We will certainly appeal this," she added.

Biocon drug gets nod for use in moderate to severe COVID-19 patients

Biocon drug gets nod for use in moderate to severe COVID-19 patients

Rediff.com11 Jul 2020

DCGI has approved to market Itolizumab (ALZUMAb) injection 25mg and 5mL solution for emergency use in India for the treatment of cytokine release syndrome (CRS) in moderate to severe ARDS (acute respiratory distress syndrome) patients due to COVID-19, Biocon said in a release.

Bengaluru Traffic Test Corporate Patience

Bengaluru Traffic Test Corporate Patience

Rediff.com20 Sep 2025

'We do not need short-term measures but long-term ones. Companies seem to have given up on the infrastructure part. Long delays are fuelling more traffic crisis.'

Rupee Slide: Tough Times For Overseas Corporate Debt

Rupee Slide: Tough Times For Overseas Corporate Debt

Rediff.com16 Jan 2025

Raising overseas debt has become prohibitively expensive due to the depreciating rupee.

Biocon to tap emerging markets to ensure growth

Biocon to tap emerging markets to ensure growth

Rediff.com23 Oct 2014

Given the gestation period for regulatory clearances it is not possible to share any definite timelines.

Priyanka Chopra among World's Top 100 Most Powerful Women

Priyanka Chopra among World's Top 100 Most Powerful Women

Rediff.com2 Nov 2017

Yet another achievement is added to PeeCee's growing list.

Itolizumab, new drug for COVID-19 patients to cost Rs 8,000 per vial

Itolizumab, new drug for COVID-19 patients to cost Rs 8,000 per vial

Rediff.com13 Jul 2020

The company has received approval from the Drugs Controller General of India (DCGI) to market Itolizumab injection 25mg/5mL solution for emergency use in India for the treatment of cytokine release syndrome in moderate to severe acute respiratory distress syndrome (ARDS) due to COVID-19.

6 women amongst India's richest people

6 women amongst India's richest people

Rediff.com19 Nov 2009

As many as six women, including O P Jindal group chairperson Savitri Jindal and Biocon's Kiran Mazumdar Shaw, have made it to the Forbes' list of 100 richest Indians this year.

SBI's Arundhati Bhattacharya most powerful Indian woman in biz

SBI's Arundhati Bhattacharya most powerful Indian woman in biz

Rediff.com9 Nov 2014

Arundhati Bhattacharya, the chairperson of country's largest bank SBI, has been named as the most-powerful woman in business in India by Fortune magazine.

'Red tape stifling India's biotech sector'

'Red tape stifling India's biotech sector'

Rediff.com15 Apr 2003

Bureaucratic delays are stifling growth in the sector. India should be far more aggressive in launching 'look alike' biological molecules in a fast track manner.

Noted economist Dr Isher Judge Ahluwalia passes away

Noted economist Dr Isher Judge Ahluwalia passes away

Rediff.com26 Sep 2020

Ahluwalia was married to former deputy chairperson of Planning Commission Montek Singh Ahluwalia and is survived by her husband and two sons.

India's rich club has only 4 women

India's rich club has only 4 women

Rediff.com22 Sep 2016

Savitri Jindal has retained the tag of being the richest woman in India with a networth of $5.2 billion

Biocon chief on why India's varsities aren't 'global'

Biocon chief on why India's varsities aren't 'global'

Rediff.com18 Mar 2014

In an interview with Business Standard, Mazumdar-Shaw spells out her plans for the institution over coming years.

Multi-agency group to probe Indian names in 'Pandora Papers'

Multi-agency group to probe Indian names in 'Pandora Papers'

Rediff.com4 Oct 2021

The government will investigate every Indian name appearing in an unprecedented leak of financial records, known as the 'Pandora Papers', which alleged that many world leaders have secret offshore stores of wealth.

Sales of Biocon's itolizumab surge as phase-4 clinical trials begin

Sales of Biocon's itolizumab surge as phase-4 clinical trials begin

Rediff.com6 Oct 2020

In India, itolizumab, known by the brand name Alzumab, has been priced at Rs 8,000 per vial. Most patients require four vials for Covid-19 treatment, taking the cost of the therapy to Rs 32,000.

India Inc pays rich tributes to Manmohan Singh

India Inc pays rich tributes to Manmohan Singh

Rediff.com27 Dec 2024

Singh, who opened up the economy as finance minister and served as prime minister for two consecutive terms, died on Thursday at the age of 92. "History will forever honour his pivotal role in the transformative 1991 reforms that reshaped India and opened its doors to the world.

How Biocon plans to fight COVID-19

How Biocon plans to fight COVID-19

Rediff.com4 Aug 2020

'I cannot cope with the demand. It will take us a couple of months to ramp up production.'

Big drugmakers step in to develop, import test kits

Big drugmakers step in to develop, import test kits

Rediff.com20 Apr 2020

Cadila, Biocon developing rapid antibody testing kits; Eris, Mylan, Gland importing. There are two kinds of testing for the novel coronavirus - the real-time polymerase chain reaction test kit that uses throat or nasal swabs and provides results in a few hours, and the other is antibody-based rapid testing kit that use blood samples and provides results in a few minutes.

Eminent economist Isher Judge Ahluwalia passes away

Eminent economist Isher Judge Ahluwalia passes away

Rediff.com26 Sep 2020

Her research was focused on urban development, macro-economic reforms, industrial development, and social sector development issues in India.

India's Covid testing data is a black hole

India's Covid testing data is a black hole

Rediff.com24 Jan 2022

'In the earlier waves, doubling of cases was happening at an interval of 4-6 days.' 'But in the case of omicron the doubling time we are seeing is in the range of 2-4 days.'

'Real growth and opportunity are going to come from GLP-1'

'Real growth and opportunity are going to come from GLP-1'

Rediff.com21 Aug 2024

'It is not just the US and European opportunity, but it is a huge global opportunity.'

Agnipath has large job potential: India Inc

Agnipath has large job potential: India Inc

Rediff.com20 Jun 2022

Industry leaders, including Mahindra Group chairman Anand Mahindra, RPG Enterprises chairman Harsh Goenka and Biocon Ltd chairperson Kiran Mazumdar-Shaw on Monday came out in support of the Agnipath scheme, saying it has large potential for employment of youth in the corporate sector. Mahindra also expressed dismay over the violence against the scheme while asserting that the farm equipment to aerospace conglomerate welcomes the opportunity to recruit trained, capable and young people under the programme. The Agnipath scheme, announced on June 14, provides for the recruitment of youths between the age bracket of 17-and-half years to 21 for only four years with a provision to retain 25 per cent of them for 15 more years.

India's 6 super achievers in Asia's powerful women list

India's 6 super achievers in Asia's powerful women list

Rediff.com27 Feb 2015

Six Indian women have made it to Asia's most powerful women list released by Forbes.

Sitharaman breaks into Forbes 100 powerful women list

Sitharaman breaks into Forbes 100 powerful women list

Rediff.com13 Dec 2019

Sitharaman, a newcomer on the Forbes most powerful women list, is ranked 34th. The Forbes 2019 list of 'The World's 100 Most Powerful Women' has been topped by German Chancellor Angela Merkel, followed by President of the European Central Bank Christine Lagarde in the second spot and Speaker of the US House of Representatives Nancy Pelosi, ranked third. Also on the list is Bangladesh Prime Minister Sheikh Hasina (29).